About the Author
Proxima CRO Team
Joel Reid
Regulatory Affairs Specialist
Throughout his experience at Proxima, Joel has developed his skills to advise companies in the best path forward in the development of drugs and devices across a range of therapeutic and diagnostic areas.

Investigations of diagnostic devices that meet the criteria at section 812.2(c)(3) are exempt from the regulations at 21 CFR 812, except for section 812.119. The criteria at section 812.2(c)(3) include specifying that testing:

  • be non-invasive,
  • not require an invasive sampling procedure that presents a significant risk,
  • not by design or intention introduce energy into a subject, and
  • not be used as a diagnostic procedure without confirmation of the diagnosis by another, medically established diagnostic product or procedure.

Related FAQs:
More Questions? We're here to help!